Ascendis Pharma A/S (Nasdaq: ASND) today announced two oral presentations at ENDO 2025, the annual meeting of the Endocrine ...

COPENHAGEN, Denmark, July 07, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced two oral presentations at ENDO 2025, the annual meeting of the Endocrine Society being ...

COPENHAGEN, Denmark, July 07, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced two oral presentations at ENDO 2025, the annual meeting of the Endocrine Society being ...

This emblem will make its full debut on July 8, when Bentley reveals a future vision concept car, previewing the next era of ...

Which NFL teams look awesome? Which ... don't? And who will be rocking new alternates, including "Rivalries" unis, during the 2025 season?

Bentley’s design DNA has always leaned into heritage, especially when it comes to its iconic “Winged B” emblem. Still, even ...

Ascendis Pharma A/S (NASDAQ:ASND) is among the 12 best healthcare stocks to buy now. On June 10, Canaccord Genuity reiterated a Hold rating on the stock and an $84 price target. The stance follows ...

Bentley has unveiled a new ‘Bentley Wings’ emblem – the first step of a design and brand revolution at the British marque.

Bentley unveils the fifth iteration of its historic Winged B logo. The modernized embled will make its debut on an ...

As part of the team's upcoming 100th anniversary celebration, the Detroit Red Wings unveiled a new anniversary logo along ...

The U.S. Food and Drug Administration (FDA) has accepted Ascendis Pharma’s New Drug Application for TransCon CNP with a priority review, setting a goal date for November 30, 2025.